Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixmyelocel-T in Critical Limb Ischemia
NCT01483898Phase 3Completed
- Sponsor
- Vericel
- Start
- Feb 2012
- Primary completion
- Mar 2014
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of ixmyelocel-T in critical limb ischemia (CLI), sponsored by Vericel. Started Feb 2012; status: completed.
02
Drugs
ixmyelocel-T
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01483898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483898.